National Diabetes Prevention Programme
Reducing your risk of diabetes - more info
Position statement 10 December 2018
In common with all CCGs across the country, and in response to a request from NHS England, our policy towards ‘flash glucose monitoring’ is being carefully reviewed.
There is no National Institute for Health and Care Excellence (NICE) guidance available and there is limited evidence to prove that this technology improves patient health, which is why it has not been supported for prescribing to date. If or when this position changes the CCG will ensure clinicians are advised and publish any criteria for eligibility.
NHS England plans to publish a set of guidelines defining which patients may receive this technology and we are awaiting the publication of their view on the clinical criteria for patient groups.
It is planned that if the guidance is made available, the Norfolk and Waveney Joint Strategic Commissioning Committee will consider this guidance in the early part of 2019 to determine how it may be utilised from April 2019.